Clinical utility of contrast echocardiography in the management of patients with acute myocardial infarction
Department of Cardiology, La Sapienza University of Rome, Rome, Italy
* Correspondence: Luciano Agati, MD, Associate Professor of Cardiology, Director, Echocardiography Laboratories, Department of Cardiology, La Sapienza University of Rome, Via del Policlinico 155, 00196 Roma, Italy.
Abstract
The extensive use of myocardial contrast echocardiography (MCE) in patients with acute myocardial infarction has provided critical information regarding the perfusion-contraction mismatch that is observed in post-ischaemic dysfunctioning segments. No-reflow phenomena, microvascular stunning, and the relation between microvascular integrity and inotropic reserve within the infarct zone represent areas in which NICE could provide useful information. Rapid technological progress has been made in echocardiographic imaging (harmonic and ultraharmonic imaging, real-time perfusion imaging), and new ultrasound contrast agents such as SonoVue (Bracco, Milan, Italy) have been introduced into the market. These have rendered non-invasive assessment of myocardial perfusion a clinical reality, and thus demonstrate the potential role of NICE in assessing myocardial salvage after reperfusion therapy and suggest that routine NICE use in a coronary care unit may be possible.
Key Words: Acute myocardial infarction myocardial contrast echocardiography SonoVue ultrasound contrast agent